Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
Updated drug information handout outdoes FDA's version in clinical trial
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Time on MSN3d
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
FDA labels broccoli sold at Walmart as deadly. See where it was sold and what you should do
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the agency.
PBS12d
The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks
These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration to ban its use in ...
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants
Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
Walmart broccoli recall: Was tainted food sold in Mississippi? FDA labels veggies deadly
Broccoli sold at Walmart in 20 states has been labeled potentially deadly in an update from the FDA. Was it sold in ...
Hosted on MSN13h
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...